[1]
Morales-Avalos, A. et al. 2021. Experience of using tocilizumab in patients with COVID-19 from a referral hospital in Peru. Revista Peruana de Medicina Experimental y Salud Pública. 38, 2 (Mar. 2021), 360–2. DOI:https://doi.org/10.17843/rpmesp.2021.382.6756.